Market Place
Sourcing Support
All News #Library
Biotech
Aspire Biopharma Announces $5.0 Million Share Repurchase Program
27 Apr 2026 //
PHARMIWEB
Aspire Biopharma Partners with Microsize on Sublingual Tech
03 Mar 2026 //
PHARMIWEB
Aspire Bio Appoints New Board Member
13 Feb 2026 //
PHARMIWEB
Aspire Bio Files Patent For Fast-Acting Ondansetron Sublingual
12 Feb 2026 //
PHARMIWEB
Aspire Bio Secures $21M Private Placement, Bolsters Financials
11 Feb 2026 //
PHARMIWEB
Aspire Bio Restores Nasdaq Minimum Bid Price Compliance
10 Feb 2026 //
PHARMIWEB
Aspire Bio Partners Microsize For Sublingual Aspirin Development
29 Jan 2026 //
PHARMIWEB
Aspire Biopharma Secures FDA Pre-IND for Sublingual OTASA
07 Jan 2026 //
PHARMIWEB
Aspire Bio Seeks FDA Pre-IND Meeting For Sublingual Aspirin
02 Dec 2025 //
PHARMIWEB
Aspire Bio Welcomes Dr. Mark J. Jaroszeski To Scientific Team
26 Nov 2025 //
PHARMIWEB
Aspire Bio Files Omnibus Patent For Sublingual Drug Delivery
06 Oct 2025 //
PHARMAWEB
Aspire Bio To Present At Noble Capital Markets 2025 Growth Conf
03 Oct 2025 //
PHARMAWEB
Aspire Bio Targets H2 2025 FDA Submission For Sublingual Aspirin
01 Oct 2025 //
PHARMIWEB
Aspire Biopharma Initiates Order for 2M Servings of BUZZ
16 Sep 2025 //
PHARMAWEB
Aspire Doses Last Patient in Ph 1 Trial of Oral High-Dose Aspirin
24 Jun 2025 //
ACCESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.